Type 2 diabetes CVD event rates and mortality
Showing 1 - 25 of >10,000
Cardiovascular Diseases, Type2diabetes Trial in Winnipeg (Peer mentorship and physical activity)
Not yet recruiting
- Cardiovascular Diseases
- Type2diabetes
- Peer mentorship and physical activity
-
Winnipeg, Manitoba, CanadaUniversity of Manitoba
Feb 10, 2023
Visual-Auditory Reaction Rates in Individuals With Type 2
Completed
- Diabetes Mellitus, Type 2
- +2 more
- recation time test
-
Ankara, TurkeyBaskent University
Feb 10, 2023
Cardiovascular Diseases, Type 2 Diabetes Trial in San Francisco (Educational Materials on the Cardiovascular Disease in Type 2
Completed
- Cardiovascular Diseases
- Type 2 Diabetes
- Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D)
- Educational Materials on the CVD-T2D and Bundled Metabolic Panel
-
San Francisco, CaliforniaQURE Healthcare
Aug 17, 2022
N-terminal Pro-B-type Natriuretic Peptide in Type 2 Diabetes
Recruiting
- Type2diabetes
- +2 more
-
Singapore, SingaporeSingapore General Hospital
Feb 22, 2023
Physical Activity and Mortality in Type 2 Diabetes
Completed
- Diabetes Mellitus, Type 2
- Leisure-time physical activity
- (no location specified)
May 15, 2022
Type 2 Diabetes, Cardiovascular Diseases Trial in Aurora (Informed of results from SomaSignal Cardiovascular Risk Test in Type 2
Recruiting
- Type 2 Diabetes
- Cardiovascular Diseases
- Informed of results from SomaSignal Cardiovascular Risk Test in Type 2 Diabetes (CVD-T2D)
- Not informed of results from SomaSignal Cardiovascular Risk Test in Type 2 Diabetes (CVD-T2D)
-
Aurora, ColoradoAanchal Gupta
Apr 12, 2022
Diabetes, Type 2 Trial in Palermo (Liraglutide injection, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Liraglutide injection
- Insulin Glargine
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
May 3, 2022
Chronic Heart Failure, Type 2 Diabetes, Cardiovascular Mortality Trial in Wuhan (Glimepiride)
Completed
- Chronic Heart Failure
- +3 more
-
Wuhan, Hubei, ChinaTongji Hospital
Sep 11, 2022
Rate and Risk Signature in Semirural Sub-Saharan Africa
Not yet recruiting
- Chronic Kidney Diseases
- +6 more
-
Bagamoyo, Pwani, TanzaniaBagamoyo District Hospital
May 19, 2023
Type 2 Diabetes, Metabolic Syndrome, Obesity, Abdominal Trial in Vienna, Kiel (synbiotic, microcrystalline cellulose)
Completed
- Type 2 Diabetes
- +3 more
- synbiotic
- microcrystalline cellulose
-
Vienna, Austria
- +1 more
May 30, 2022
The Sapienza University Mortality and Morbidity Events Rate
Recruiting
- Type 2 Diabetes Mellitus
-
Rome, RM, ItalyUniversity of Roma La Sapienza
Sep 28, 2021
Diabetes, Type 2, Adverse Event, Blood Pressure Trial in Guangzhou (Allisartan Isoproxil, Amlodipine 5mg, Standard treatment by
Recruiting
- Diabetes Mellitus, Type 2
- +4 more
- Allisartan Isoproxil
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Jan 3, 2022
Adverse Drug Event, Effect of Drug, Type 2 Diabetes Treated With Insulin Trial in Lahore (Insulin)
Active, not recruiting
- Adverse Drug Event
- +2 more
-
Lahore, Punjab, PakistanSocial Security Hospital
Dec 20, 2021
Type 2 Diabetes Trial in Leeds (Freestyle libre, Nurse led structured intervention - hypoglycaemia education and diabetes
Not yet recruiting
- Type 2 Diabetes
- Freestyle libre
- Nurse led structured intervention - hypoglycaemia education and diabetes treatment modification modification
-
Leeds, West Yorkshire, United KingdomDiabetes centre, St James hospital
Sep 7, 2021
Glucose Metabolism, Lipid Metabolism Trial in Maastricht (10 g of collagen hydrolysate, Placebo)
Recruiting
- Glucose Metabolism
- Lipid Metabolism
- 10 g of collagen hydrolysate
- Placebo
-
Maastricht, NetherlandsMaastricht University Medical Center
Mar 8, 2022
Type 2 Diabetes, Cardiovascular Diseases Trial in Odense (CAC-based treatment strategy, Standard treatment)
Recruiting
- Type 2 Diabetes
- Cardiovascular Diseases
- CAC-based treatment strategy
- Standard treatment
-
Odense, DenmarkOdense University Hospital
Jan 18, 2023
Type 2 Diabetes Trial in Bronx (glucagon like peptide-1, glucose control)
Completed
- Type 2 Diabetes
- glucagon like peptide-1
- glucose control
-
Bronx, New YorkAlbert Einstein College of Medicinie
Apr 21, 2021
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Recruiting
- Type 2 Diabetes Mellitus
- Cardiovascular Diseases
- SU
- +13 more
-
Oakland, California
- +5 more
Oct 18, 2022
Type 2 Diabetes Trial in Uppsala (Metformin, Dapagliflozin 10 MG)
Recruiting
- Type 2 Diabetes
- Metformin
- Dapagliflozin 10 MG
-
Uppsala, SwedenUppsala University Hospital
Apr 27, 2021
Use of AI in Cardiometabolic Risk Prediction in Asian Indians
Recruiting
- Type2diabetes
- Medical and Clinical History
-
New Delhi, Delhi, IndiaFortis Cdoc Hospital
Jul 11, 2023
Diabete Type 2, Unstable Angina, Myocardial Infarction Trial in Leon (Dapagliflozin 10Mg Tab, Placebo)
Completed
- Diabete Type 2
- +3 more
- Dapagliflozin 10Mg Tab
- Placebo
-
Leon, Guanajuato, MexicoUnidad Medica de Alta Especialidad No. 1, Bajío
Aug 16, 2023
Cardiovascular Diseases, Heart Failure, Type 1 Diabetes Trial (Aspirin tablet, Semaglutide, Sotagliflozin)
Not yet recruiting
- Cardiovascular Diseases
- +3 more
- Aspirin tablet
- +3 more
- (no location specified)
Oct 8, 2023
New Users of SGLT-2 Inhibitors
Completed
- Diabetes Mellitus Type 2
-
Wilmington, Delaware
- +16 more
Feb 17, 2021
Overweight and Obesity, Cardiovascular Risk Factor Trial in Al Ain (Family-based diet and exercise intervention)
Not yet recruiting
- Overweight and Obesity
- Cardiovascular Risk Factor
- Family-based diet and exercise intervention
-
Al Ain, Abu Dhabi, United Arab EmiratesKanad Hospital
Feb 27, 2022